G. Linker

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.

Trey Sunderland, J. Bartko, T. Sunderland, 2003, JAMA.

Decreased (cid:1) -Amyloid 1-42 and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease

J. Bartko, T. Sunderland, R. Cohen, 2003 .

High Lights Anesthesia Management of Patients with Mental Retardation Effect of Acetaminofen Versus Lornoxicam Admistration on Oxidative Stress Relationship Between Premature ventricular complexes and Neutrophil Lymphocyte Ratio Treatment Of Postoperative Atelectasis With Dornase Alpha ( Pulmozyme

Pau, G. Barolat, H. Demirtaş, 2016 .

Fine-needle, negative-pressure lumbar puncture: A safe technique for collecting CSF

G. Linker, K. Putnam, G. Manetti, 2002, Neurology.

Chromosome 17q linkage studies of 18 Utah breast cancer kindreds.

M H Skolnick, J H Ward, A Oliphant, 1993, American journal of human genetics.

Decreased-Amyloid 1-42 and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease

Trey Sunderland, J. Bartko, T. Sunderland, 2003 .

Context-specific memory and apolipoprotein E (ApoE) ε4: Cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease

F. Lalonde, T. Sunderland, R. Cohen, 2004, Journal of the International Neuropsychological Society.

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.

Holly Soares, Trey Sunderland, Gyorgy Csako, 2004, Biological psychiatry.

Cerebrospinal fluid β-amyloid1–42 and tau in control subjects at risk for Alzheimer’s disease: The effect of APOE ε4 allele

Holly Soares, Trey Sunderland, Gyorgy Csako, 2004, Biological Psychiatry.